Search Result

• All
• Related Products
• Other Content

• Instructions for Use of Pichia Residual DNA Detection Kit (qPCR)
• Industry Insight | CAR-NK Cell Therapy Shows Complete Responses in Waldenström Macroglobulinemia April 2026 - Recent clinical findings highlight the growing potential of CAR-NK cell therapy in the treatment of hematologic malignancies. A study reported that a CD19-targeted CAR-NK therapy achie... More+
• Instructions for Use of Kanamycin ELISA Detection Kit-2G
• Industry Insight | Order No. 818 Is Coming Into Effect | Key Compliance Requirements for Cell Therapy Clinical Research On February 24, 2026, the National Health Commission of China (NHC) released an official interpretation of Order No. 818 – Regulation on the Management of Clinical Research and Translational Applicat... More+
• Instructions for Use of Host Cell Residual DNA Sample Preprocessing Kit (Magnetic Bead Method)
• Industry Insight | Breakthrough in NK Cell Manufacturing Highlights the Need for Scalable Expansion Platforms April 2026 - Recent advances in NK cell manufacturing are drawing renewed attention to one of the most critical challenges in cell therapy development: scalable and efficient cell expansion. A newly r... More+
• Instructions for Use of Lentivirus Titer p24 Rapid ELISA Detection Kit
• Industry Insight | Proposed U.S. Tariffs on Pharmaceutical Imports Could Reshape Biotech Supply Chains April 2026 - Recent policy discussions in the United States are raising new questions for the global biopharmaceutical industry. The administration of Donald Trump is reportedly considering tariffs on... More+
• Industry Insight | CAR-NK Therapy Moves Toward Outpatient Treatment Model April 2026 - The clinical development of CAR-NK cell therapies may be entering a new phase as treatment logistics become simpler and more accessible. Recently, Nkarta announced that it has reached an ... More+
• Industry Insight | New Target Identified for CAR-NK Therapy in Acute Myeloid Leukemia April 2026 - Researchers and biotechnology companies continue to expand the potential of natural killer (NK) cell therapies as new targets and engineering strategies emerge. Recently, Precision Biolog... More+
• Industry Insight | New Glycan Target May Advance CAR-NK Therapy for AML April 2026 - Researchers are continuing to uncover new biological targets that could expand the potential of engineered immune cell therapies. Recently, Precision Biologics reported the identification... More+
• Industry Insight | Eli Lilly to Acquire Kelonia Therapeutics in $7 Billion Cell Therapy Deal April 2026 - Eli Lilly and Company has announced plans to acquire biotechnology firm Kelonia Therapeutics in a deal valued at up to $7 billion, highlighting the growing strategic importance of next-ge... More+
• Focus on Collaboration | Hillgene Biopharma Attends China-Korea Business Exchange to Explore New Opportunities in the Cell Therapy Industry On April 21, a South Korean business delegation visited Wuzhong District, where the Wuzhong District People’s Government and the Korea Bio-Pharma Association jointly organized a China-South Korea Bus... More+
• Instructions for Use of Lentivrial Vector RNA Copy Number Detection Kit